MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$4,866,635
EPS
-$0.2
Unit: Dollar

Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
2,066,825 2,565,244 2,878,529.5* 2,177,922
General and administrative
2,839,763 3,140,712 2,454,900* 3,294,456
Total operating expenses
4,906,588 5,705,956 5,333,429.5 5,472,378
Loss from operations
-4,906,588 -5,705,956 -5,333,429.5* -5,472,378
Change in estimated fair value of warrant liability
--0* 0
Gain on settlement of warrants
--0* 0
Loss on issuance of related party convertible notes payable at fair value
--0* 0
Change in estimated fair value of related party convertible notes payable
--0* 0
Interest expense
5,063 5,062 5,062.5* 5,063
Interest income
45,016 85,269 145,952.5* 69,971
Total other income, net
39,953 80,207 140,890* 64,908
Net loss
-4,866,635 -5,625,749 -5,192,539.5 -5,407,470
Basic EPS
-0.2 -0.24 -0.236 -0.25
Diluted EPS
-0.2 -0.24 -0.236 -0.25
Basic Average Shares
23,871,850 23,537,134 22,024,011 21,394,965
Diluted Average Shares
23,871,850 23,537,134 22,024,011 21,394,965
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Interest income$45,016 (83.48%↑ Y/Y)Net loss-$4,866,635 (18.20%↑ Y/Y)Total other income,net$39,953 (105.18%↑ Y/Y)Interest expense$5,063 (0.02%↑ Y/Y)Loss from operations-$4,906,588 (17.80%↑ Y/Y)Total operatingexpenses$4,906,588 (-17.80%↓ Y/Y)General andadministrative$2,839,763 (-11.37%↓ Y/Y)Research and development$2,066,825 (-25.25%↓ Y/Y)

ACTUATE THERAPEUTICS, INC. (ACTU)

ACTUATE THERAPEUTICS, INC. (ACTU)